[go: up one dir, main page]

MD3592G2 - Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma - Google Patents

Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma

Info

Publication number
MD3592G2
MD3592G2 MDA20070302A MD20070302A MD3592G2 MD 3592 G2 MD3592 G2 MD 3592G2 MD A20070302 A MDA20070302 A MD A20070302A MD 20070302 A MD20070302 A MD 20070302A MD 3592 G2 MD3592 G2 MD 3592G2
Authority
MD
Moldova
Prior art keywords
preparation
uterotonic
hysteromyoma
case
treating uterine
Prior art date
Application number
MDA20070302A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3592F1 (en
Inventor
Виктор ГИКАВЫЙ
Рафаэль Баркан
Original Assignee
Рафаэль Баркан
Виктор ГИКАВЫЙ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рафаэль Баркан, Виктор ГИКАВЫЙ filed Critical Рафаэль Баркан
Priority to MDA20070302A priority Critical patent/MD3592G2/en
Publication of MD3592F1 publication Critical patent/MD3592F1/en
Priority to UAA201006063A priority patent/UA104847C2/en
Priority to CN200880123695.5A priority patent/CN101917848B/en
Priority to PCT/IL2008/001466 priority patent/WO2009060451A2/en
Priority to EP08846478.9A priority patent/EP2219447B1/en
Priority to EA201000732A priority patent/EA030035B1/en
Priority to US12/741,759 priority patent/US20100305210A1/en
Publication of MD3592G2 publication Critical patent/MD3592G2/en
Priority to IL205535A priority patent/IL205535A/en
Priority to US16/944,137 priority patent/US12011423B2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention refers to medicine, in particular to pharmacology and gynecology.Summary of the invention consists in using diethyl phosphate of S-ethylisothiouronium as uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma.The result of the invention consists in that at local use of the given medicinal preparation in 88% cases it is obtained a complete hemostasis in a short time interval and without side effects.
MDA20070302A 2007-11-06 2007-11-06 Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma MD3592G2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
MDA20070302A MD3592G2 (en) 2007-11-06 2007-11-06 Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma
UAA201006063A UA104847C2 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
CN200880123695.5A CN101917848B (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
PCT/IL2008/001466 WO2009060451A2 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
EP08846478.9A EP2219447B1 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
EA201000732A EA030035B1 (en) 2007-11-06 2008-11-06 Use of s-ethylisothiouronium diethylphosphate for the manufacture of a medicament for treating a uterine hypercontractility disorder
US12/741,759 US20100305210A1 (en) 2007-11-06 2008-11-06 S-alkylisothiouronium derivatives for treating abnormal uterine bleeding disorders
IL205535A IL205535A (en) 2007-11-06 2010-05-04 S- alkylisothiouronium derivatives for treating uterine hypercontractility disorders
US16/944,137 US12011423B2 (en) 2007-11-06 2020-07-30 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20070302A MD3592G2 (en) 2007-11-06 2007-11-06 Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma

Publications (2)

Publication Number Publication Date
MD3592F1 MD3592F1 (en) 2008-05-31
MD3592G2 true MD3592G2 (en) 2008-12-31

Family

ID=39471731

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20070302A MD3592G2 (en) 2007-11-06 2007-11-06 Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma

Country Status (2)

Country Link
MD (1) MD3592G2 (en)
UA (1) UA104847C2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2323G2 (en) * 2003-06-23 2004-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2323G2 (en) * 2003-06-23 2004-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Paladi G. Ginecologie. Editura ARC, Chişinău, 1997, p. 133-140 *
Surcel V.I. Fibromiomul uterin. Editura Dacia, Cluj, 1998 *
Surcel V.I. Fibromiomul uterin. Editura Dacia, Cluj, 1998, p. 124 *
А.Ф. Диагностика и лечение дисфункциональных маточных *
Добротина А.Ф. Диагностика и лечение дисфункциональных маточных кровотечений. Медицина, 1978, p.221 *

Also Published As

Publication number Publication date
MD3592F1 (en) 2008-05-31
UA104847C2 (en) 2014-03-25

Similar Documents

Publication Publication Date Title
WO2008129396A3 (en) Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding
MX343688B (en) Tricyclic pyrazole sulfonamide compounds and methods of making and using same.
MX2020001513A (en) Clec9a binding agents and use thereof.
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
TW200605870A (en) Topical methadone compositions and methods for using the same
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
MX339201B (en) Sulphonamide compounds and methods of making and using same.
EP3974453A3 (en) Agents and methods for treating diseases that correlate with bcma expression
PH12013502261A1 (en) Partially saturated tricyclic compounds and methods of making and using same
MX2019012657A (en) Inhibitors of bruton's tyrosine kinase.
GB2490084A (en) Methods and compositions to treat hemorrhagic conditions of the brain
PH12017501688A1 (en) Intranasal benzodiazepine pharmaceutical compositions
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
MY173215A (en) Acetylcysteine compositions and methods of use thereof
MX2014008706A (en) Tricyclic sulfonamide compounds and methods of making and using same.
WO2009121872A3 (en) Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
PH12015500062A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
AU316078S (en) Surgical tissue stimulator/locator
MX2009006327A (en) Heterocycle compounds and methods of use thereof.
MX2019008817A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
DE502005005636D1 (en) Spirocyclische cyclohexan-derivate
PH12012501389A1 (en) Hedgehog inhibitors
MX2015005732A (en) Tricyclic compounds and methods of making and using same.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees